Activity
2K followers
-
ercole lardini liked thisNearly 20 years in sterile drug product & fill-finish — and I'm still learning every day. 🙌 That's what I love most about this field: it never stops evolving. As a cross-functional connector, I genuinely enjoy bridging the gap between partners to improve processes, solve complex challenges, and move things forward together. I had the opportunity to share some of that expertise in this article: 👉 Fill-Finish Is Never Just Fill-Finish https://lnkd.in/gnJW_FKx A big thank you to Dora W. & PharmaSource for the platform and the collaboration. 🤝 #CDMO #CrossFunctional #DrugProduct #FillFinish #Pharma #SterileManufacturing #CombinationProduct #Manufacturingercole lardini liked thisFill-finish is never “just” fill-finish. As Carole Delauney highlights, sterile injectable manufacturing has evolved into a highly interconnected system where drug substance, primary packaging, fill-finish, device assembly, sterilization, and final configuration are all tightly interdependent. In practice, especially in areas like intravitreal (IVT) products, a decision on something as “simple” as a prefilled syringe format can cascade across line compatibility, sterilization method (EO, VHP, NO₂), packaging configuration (e.g. blister systems), and component lead times, which can reach ~40–50 weeks for custom parts. The most effective CDMO and supply strategies increasingly come from partners who can: - Understand the full end-to-end manufacturing chain - Anticipate interface risks early - Coordinate across multiple specialist suppliers - Be transparent about real manufacturing constraints As Carole notes, integrated thinking reduces development risk. Full article here: https://lnkd.in/g9ZjeNBe Carole will be leading a panel at CDMO Live Europe, Rotterdam, May 19-21st titled: Mastering the Drug Substance to Fill Finish Journey for Biologics: From Cell Line Development to Vial #fillfinish #CDMO #pharmaceuticalmanufacturing #combinationproducts
-
ercole lardini liked thisercole lardini liked this🌍 International Women’s Day At Delpharm, we firmly believe that sustainable performance is built on diversity, equity, and equal opportunities. 👩🔬 43% women across the Group 👩💼 40% women on the Sites Leadership These figures reflect our concrete commitment to gender balance and the advancement of women in the pharmaceutical industry. Today, we give the floor to Catherine Boulange, Group Quotation & Life Cycle Management Director. She shares her perspective on women’s representation at Delpharm and on the actions that help drive equality forward every day. 🎥 Watch her testimony in the video below. #InternationalWomensDay #GenderEquality #WomenInPharma #DiversityAndInclusion #LetsDevelopOurFutureTogether #Delpharm
-
ercole lardini liked thisercole lardini liked thisPharmaSource is bringing #CDMOLive back to Rotterdam in May 🌷 ! Are you ready to join us? 🤝 I am thrilled to announce that I will be hosting a 40-minute panel discussion with Christelle Dagoneau, Founder & Senior Advisor at CD BioPartners, and Mairead Looby, Executive Director, Technical Operations at Merck. The discussion will focus on the #development and #manufacturing of #biological #drugsubstances and #sterile #injectable #drugproducts, and we will share our perspectives and insights on critical #CMC issues, as well as emphasising how #partnerships can create value. #cdmo #CDMOindustry #pharmaceuticalmanufacturing #externalmanufacturing
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More